CWI and Discharge After Breast Cancer Surgery

• Status: Completed
• Trial end date: 2018-07-31
• Target enrollment: 0
• Participant gender: Female

Summary

The objectives of this work are threefold:

1. To evaluate the analgesic efficacy of CWI in women discharged within 23 hours of major breast cancer surgery

2. To evaluate objective indices of patient recovery following anaesthesia and surgery in a 23 hour model of care

3. To evaluate patient satisfaction with their care pathway

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University College Cork
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

Women undergoing any one of:

mastectomy mastectomy with axillary lymph node clearance mastectomy with axillary lymph node sampling

Exclusion Criteria:

Refusal to participate; Allergy to Bupivacaine; Pre-existing pain conditions; Regular use of opioid analgesia; Pregnancy; Uncontrolled Diabetes; Uncontrolled Thyroid disorder; Severe cardiac, renal or hepatic disease ; Bilateral surgery; Planned discharge >23 hours; Travel time from the admitting hospital >45 minutes; Absence of intellectual capacity to consent